Leprosy

Novartis Foundation and Partners Call for a Global Effort to Make Leprosy History

In two articles in the Lancet Infectious Diseases, the Novartis Foundation and its partners review the historic and future innovations and game-changing strategies in leprosy elimination, calling for a global effort to make leprosy history.
Press Release

July 10, 2017 /3BL Media/  - On July 7th, 2017 the Novartis Foundation and its partners published two articles that call for a global effort to make leprosy history. The reviews have been published in the Lancet Infectious Diseases, a leading journal in infectious diseases.[i]

Novartis Foundation and Fiocruz Convene Global Experts on Strategies for Leprosy Detection

Today in Rio de Janeiro, Brazil, researchers, policy makers and public partners with a shared interest in determining strategies to detect leprosy and stop its global transmission come together
Press Release

May 30, 2017 /3BL Media/ - On May 30, 2017 together with the Oswaldo Cruz Foundation (Fiocruz), a premier research institution in Brazil focused on public health, the Novartis Foundation is co-hosting an expert meeting entitled ‘Strategies to detect and interrupt the global transmission of leprosy’ in Rio de Janeiro, Brazil.

World Leprosy Day: 4 Stories That Show the Ongoing Impact of Leprosy

The Novartis Foundation shares four new Global Health Stories to highlight the impact of leprosy on patients, families and communities and our work to stop it.
Article

As part of the Novartis Foundation’s effort to document the impact of leprosy on patients, their families and communities – as well as our work to stop it – we have added four new entries to our visual story-telling platform, called Global Health Stories.

Novartis Foundation Commemorates World Leprosy Day with its Continued Efforts to go the Last Mile Toward Elimination

2016 marks 30 years of commitment by the Novartis Foundation to support people affected by leprosy and to end this ancient disease
Summary: 
  • 2016 marks 30 years of commitment by the Novartis Foundation to support people affected by leprosy and to end this ancient disease

  • New strategy from the Novartis Foundation to accelerate elimination is focused on interrupting transmission of the disease

  • Last year Novartis renewed its commitment with the WHO to donate multidrug therapy to treat leprosy through the year 2020

  • More than 200,000 people are diagnosed with leprosy every year; approximately 10% of those are children, indicating continued spread of the disease
Press Release
  • 2016 marks 30 years of commitment by the Novartis Foundation to support people affected by leprosy and to end this ancient disease

  • New strategy from the Novartis Foundation to accelerate elimination is focused on interrupting transmission of the disease

  • Last year Novartis renewed its commitment with the WHO to donate multidrug therapy to treat leprosy through the year 2020

  • More than 200,000 people are diagnosed with leprosy every year; approximately 10% of those are children, indicating continued spread of the disease

Novartis Continues Commitment to go the Last Mile in Effort to Eliminate Leprosy

New five-year commitment includes donation of treatments worth more than USD 40 million and is expected to reach an estimated 1.3 million patients
Summary: 

Novartis continues commitment to go the last mile in effort to eliminate leprosy

  • New five-year commitment includes donation of treatments worth more than USD 40 million and is expected to reach an estimated 1.3 million patients
     
  • Novartis Foundation’s new leprosy contact tracing program now launched in five countries
     
  • The company and foundation have a strong legacy in the fight against leprosy, donating medicines and developing programs to improve care of patients
Press Release

Novartis continues commitment to go the last mile in effort to eliminate leprosy

  • New five-year commitment includes donation of treatments worth more than USD 40 million and is expected to reach an estimated 1.3 million patients
     
  • Novartis Foundation’s new leprosy contact tracing program now launched in five countries
     
  • The company and foundation have a strong legacy in the fight against leprosy, donating medicines and developing programs to improve care of patients

Novartis Foundation Leprosy Elimination Dialogue Event Press Release

Novartis Foundation is convening global health experts at a summit in Brazil to discuss the current state of leprosy treatment & care
Press Release

The Novartis Foundation convenes experts to help finish the last mile in leprosy elimination

Subscribe to Leprosy